Drug factory · FDA FEI 3008309828
Yaopharma Co., Ltd.
No.100, Xingguang Avenue, Chongqing, China
Problems found, fixed voluntarily at FDA's last inspection, Mar 29, 2019.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2013: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Duloxetine | Makes it | Yaopharma Co., Ltd. | 50771-201, 50771-202, 50771-203 |
| Entecavir | Makes it | Yaopharma Co., Ltd. | 50771-013, 50771-014 |
| Venlafaxine | Makes it | TruPharma LLC., Yaopharma Co., Ltd. | 52817-130, 52817-131, 52817-132 +7 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 29, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 29, 2016 | No problems found | Drug Quality Assurance | — |
| Jul 11, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.